# Celleste Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/celleste-bio

- Industry: Food
- Headquarters: Tel Aviv-Jaffa, Israel
- Website: www.celleste-bio.com/
- Total disclosed funding: $4.5M
- Latest round: Seed (Dec 5, 2024)
- Investors on record: 7

## About

Based in Israel and founded in 2022, Celleste Bio Ltd specializes in the production of cocoa products through cell culture technologies. Hanne Volpin (CEO), Avishai Levy, Orna Harel, and Daphna Michaeli are the co-founders of the company. In November 2022, Celleste Bio raised seed funding from Barrel Ventures, Mondelez Global LLC, Regba Group, and Trendlines Group. In December 2024, Celleste Bio Ltd. raised USD 4 million in seed funding led by new investor Supply Change Capital, with participation from returning investors Barrel Ventures, Regba Group, and Trendlines Group. Other new investors Consensus Business Group, SnackFutures, and other unspecified investors also participated in the round.

The company produces cocoa ingredients from naturally occurring cocoa cells without genetic modification or manipulation. The firm's technology ensures cocoa yield supply is invariable, not dependent on climate conditions, close to production sites, and a final product of good quality.

## Funding rounds

- Seed, Dec 5, 2024, $4.5M — Consensus Business Group, Trendlines Group, Barrel Ventures, Supply Change Capital, Regba Group, SnackFutures
- Seed, Nov 7, 2022 — Mondelez Global LLC, Trendlines Group, Barrel Ventures, Regba Group

## Investors

- Mondelez Global LLC — Seed
- Trendlines Group (https://capitalatlas.ai/funds/trendlines-group) — Seed
- Barrel Ventures (https://capitalatlas.ai/funds/barrel-ventures) — Seed
- Regba Group — Seed
- Consensus Business Group — Seed
- Supply Change Capital (https://capitalatlas.ai/funds/supply-change-capital) — Seed
- SnackFutures (https://capitalatlas.ai/funds/snackfutures) — Seed